17-31335031-G-A
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_001042492.3(NF1):c.6006G>A(p.Gln2002=) variant causes a splice region, synonymous change. The variant allele was found at a frequency of 0.00000663 in 150,738 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. Q2002Q) has been classified as Pathogenic.
Frequency
Consequence
NM_001042492.3 splice_region, synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NF1 | NM_001042492.3 | c.6006G>A | p.Gln2002= | splice_region_variant, synonymous_variant | 40/58 | ENST00000358273.9 | |
NF1 | NM_000267.3 | c.5943G>A | p.Gln1981= | splice_region_variant, synonymous_variant | 39/57 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NF1 | ENST00000358273.9 | c.6006G>A | p.Gln2002= | splice_region_variant, synonymous_variant | 40/58 | 1 | NM_001042492.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000663 AC: 1AN: 150738Hom.: 0 Cov.: 29
GnomAD4 exome Cov.: 30
GnomAD4 genome AF: 0.00000663 AC: 1AN: 150738Hom.: 0 Cov.: 29 AF XY: 0.00 AC XY: 0AN XY: 73434
ClinVar
Submissions by phenotype
Neurofibromatosis, type 1 Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Mar 15, 2022 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 02, 2023 | For these reasons, this variant has been classified as Pathogenic. This variant disrupts the c.5943G nucleotide in the NF1 gene. Other variant(s) that disrupt this nucleotide have been determined to be pathogenic (PMID: 31766501). This suggests that this nucleotide is clinically significant, and that variants that disrupt this position are likely to be disease-causing. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this variant results in ctivation of a cryptic splice site and introduces a premature termination codon (PMID: 27322474; Invitae). The resulting mRNA is expected to undergo nonsense-mediated decay. ClinVar contains an entry for this variant (Variation ID: 1298697). This variant has been observed in individual(s) with neurofibromatosis (PMID: 27322474). This variant is not present in population databases (gnomAD no frequency). This sequence change affects codon 1981 of the NF1 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the NF1 protein. RNA analysis indicates that this variant induces altered splicing and may result in an absent or disrupted protein product. - |
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Sep 01, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Sep 28, 2023 | Alters the last nucleotide of the exon and has been demonstrated to result in aberrant splicing leading to a predicted null allele in a gene for which loss of function is a known mechanism of disease (Wimmer et al., 2007; Evans et al., 2016); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 27322474, 17311297) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at